NanoSphere Health Sciences Inc.
NSHS
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -234.75% | 51.44% | -90.50% | 74.82% | 76.92% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 105.61% | -98.01% | 83.84% | -135.16% | -251.94% |
| Change in Net Operating Assets | -63.52% | -78.03% | -85.60% | -194.44% | -15.49% |
| Cash from Operations | -214.22% | -149.90% | -115.65% | -37.76% | 22.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -54.55% | 66.67% | 635.00% | -103.25% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -54.55% | 66.67% | 635.00% | -103.25% | -- |
| Foreign Exchange rate Adjustments | 157.01% | 134.54% | 191.43% | 1,035.09% | -805.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -126.09% | -200.00% | 93.88% | 85.32% | -84.25% |